0001213900-20-025762.txt : 20200909 0001213900-20-025762.hdr.sgml : 20200909 20200909114757 ACCESSION NUMBER: 0001213900-20-025762 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200909 DATE AS OF CHANGE: 20200909 EFFECTIVENESS DATE: 20200909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Advanced Bio Development, Inc. CENTRAL INDEX KEY: 0001696505 IRS NUMBER: 320257410 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-375082 FILM NUMBER: 201165959 BUSINESS ADDRESS: STREET 1: 270 SYLVAN AVENUE STREET 2: SUITE 2230 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: 845.365.3838 MAIL ADDRESS: STREET 1: 270 SYLVAN AVENUE STREET 2: SUITE 2230 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 D 1 primary_doc.xml X0708 D LIVE 0001696505 Advanced Bio Development, Inc. 270 SYLVAN AVENUE SUITE 2230 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 (845) 365-3838 DELAWARE None None Corporation true Ralph Ferrante 270 Sylvan Avenue Suite 2230 Englewood Cliffs NJ NEW JERSEY 07632 Director M. Todd Bartee 599 West Putnam Avenue Greenwich CT CONNECTICUT 06830 Director Michael Farello 599 West Putnam Avenue Greenwich CT CONNECTICUT 06830 Director Michael Tannenbaum 599 West Putnam Avenue Greenwich CT CONNECTICUT 06830 Director Mark French 270 Sylvan Avenue Suite 2230 Englewood Cliffs NJ NEW JERSEY 07632 Director Michael Miller 270 Sylvan Avenue Suite 2230 Englewood Cliffs NJ NEW JERSEY 07632 Executive Officer Other Decline to Disclose 06b false 2020-09-01 false true true true Promissory Note is convertible into Series D Preferred Stock false 0 12000000 12000000 0 false 12 0 0 0 true Proceeds may be used to pay overhead and other corporate expenses which could include salaries. false Advanced Bio Development, Inc. /s/ Michael Miller Michael Miller Chief Financial Officer 2020-09-09